Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2025-12-24 @ 1:05 PM
NCT ID:
NCT00263861
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of solid tumor
* Metastatic disease (stage IV)
* Planning neoadjuvant or adjuvant treatment of locoregional definitive or systemic therapy comprising ≥ 1 of the following:
* Taxane (paclitaxel or docetaxel)
* Platinum (cisplatin, carboplatin, or oxaliplatin)
* Diagnosis of type I or II diabetes mellitus
PATIENT CHARACTERISTICS:
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* No other disease that reduces peripheral nerve function (e.g., HIV/AIDS, uremia, spinal injuries, alcoholism, or CNS problems)
PRIOR CONCURRENT THERAPY:
Chemotherapy
* See Disease Characteristics
* No prior chemotherapy
* No prior or concurrent neurotoxic drugs (i.e., vincristine)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00263861
Study Brief:
Protocol Section:
NCT00263861